COMPANY
Fermalogic, Inc.
NIH awards 24
- NIH award 1R43GM086989-01 FY2009: $237,825 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Engineering industrial fermentations for renewable source ↗
- NIH award 2R44GM079893-02 FY2008: $491,478 awarded for that fiscal year; activity R44 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Industrial Metabolic Engineering source ↗
- NIH award 1R43GM079946-01A1 FY2007: $380,417 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Metabolic engineering of the methylmalonyl-CoA n source ↗
- NIH award 1R43GM079893-01 FY2007: $210,631 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Industrial Metabolic Engineering source ↗
- NIH award 5R44GM063278-03 FY2005: $535,062 awarded for that fiscal year; activity R44 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Antibiotic Gene Clusters source ↗
- NIH award 1R43AI063887-01 FY2005: $404,334 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Engineering metabolic flow for rapamycin productio source ↗
- NIH award 2R44GM063278-02A1 FY2004: $430,489 awarded for that fiscal year; activity R44 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Antibiotic Gene Clusters source ↗
- NIH award 5R44CA093165-03 FY2004: $418,635 awarded for that fiscal year; activity R44 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Economical Soy Isoflavone Production source ↗
- NIH award 2R44CA093165-02 FY2003: $575,403 awarded for that fiscal year; activity R44 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Economical Soy Isoflavone Production source ↗
- NIH award 1R43AI053926-01 FY2003: $265,404 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Novel Macrolide and Ketolide Antibiotic Intermedia source ↗
- NIH award 5R44GM058943-03 FY2002: $318,047 awarded for that fiscal year; activity R44 (SBIR); PI REEVES, ANDREW R; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Antibiotic Regulatory Genes and Metabolic Engine source ↗
- NIH award 2R44GM058943-02A1 FY2001: $334,900 awarded for that fiscal year; activity R44 (SBIR); PI REEVES, ANDREW R; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Antibiotic Regulatory Genes and Metabolic Engi source ↗
- NIH award 1R43CA093165-01 FY2001: $105,000 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Economical Soy-Isoflavone Production source ↗
- NIH award 1R43GM063278-01 FY2001: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. Antibiotic Gene Clusters source ↗
- NIH award 1R43GM061414-01 FY2000: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI REEVES, ANDREW R; recipient as written: FERMALOGIC, INC., CHICAGO, IL. GLOBAL REGULATORS OF SECONDARY METABOLISM source ↗
- NIH award 1R43GM058943-01A1 FY1999: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. ANTIBIOTIC REGULATORY GENES AND METABOLIC ENGINE source ↗
- NIH award 1R43GM057730-01 FY1998: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. ERYTHROMYCIN ANALOGS BY METABOLIC ENGINEERING source ↗
- NIH award 1R43GM057122-01A1 FY1998: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. METABOLIC ENGINEERING OF ANTIBIOTIC BIOSYNTHESIS source ↗
- NIH award 1R43AI040829-01A1 FY1997: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. MOLECULAR BIOTAILORING OF MACROLIDE ANTIBIOTICS source ↗
- NIH award 5R44AI034698-03 FY1996: $360,324 awarded for that fiscal year; activity R44 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. GENETIC DESIGNS FOR HIGH EFFICIENCY MACROLIDE PROD source ↗
- NIH award 2R44AI034698-02 FY1995: $389,620 awarded for that fiscal year; activity R44 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. GENETIC DESIGNS FOR HIGH EFFICIENCY MACROLIDE PROD source ↗
- NIH award 1R43CA064006-01 FY1994: $68,000 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. CHEMOPREVENTIVE ISOFLAVONES FROM MICROORGANISMS source ↗
- NIH award 1R43AI034698-01 FY1993: $49,960 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. GENETIC DESIGNS FOR HIGH-EFFICIENCY MACROLIDE PRODU source ↗
- NIH award 1R43GM048945-01 FY1993: $49,998 awarded for that fiscal year; activity R43 (SBIR); PI WEBER, J. MARK; recipient as written: FERMALOGIC, INC., CHICAGO, IL. IMMUNOSUPPRESSANT ANALOGS THROUGH TARGETED GENETICS source ↗